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A B S T R A C T
The original CODIS database based on 13 core STR loci has been overwhelmingly successful for matching
suspects with evidence. Yet there remain situations that argue for inclusion of more loci and increased
discrimination. The PowerPlex1 Fusion System allows simultaneous ampliﬁcation of the following loci:
Amelogenin, D3S1358, D1S1656, D2S441, D10S1248, D13S317, Penta E, D16S539, D18S51, D2S1338,
CSF1PO, Penta D, TH01, vWA, D21S11, D7S820, D5S818, TPOX, DYS391, D8S1179, D12S391, D19S433, FGA,
and D22S1045. The comprehensive list of loci ampliﬁed by the system generates a proﬁle compatible with
databasesbasedoneitherthe expandedCODIS or EuropeanStandardSet (ESS)requirements.Developmental
validation testing followed SWGDAM guidelines and demonstrated the quality and robustness of the
PowerPlex1Fusion System across a number of variables. Consistent and high-quality results were compiled
using data from 12 separate forensicand research laboratories. The results verifythat the PowerPlex1Fusion
System is a robust and reliable STR-typing multiplex suitable for human identiﬁcation.
 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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The discrimination power of STR technology is derived from the
combination of allele calls at multiple loci. By combining several
independent loci, scientists can identify individuals precisely and
with signiﬁcant supporting probabilities. The current US database,
which is based on the CODIS 13 core STR loci, has been
overwhelmingly successful for matching suspects with evidence.
Yet there remain situations that argue for inclusion of more loci
and increased discrimination. Additional loci would aid in missing
persons cases and distinguish family members in closely related
communities. Furthermore, with expanded locus overlap between
multiple databases, global cooperation and data exchange would
be facilitated. Both the European and US forensic communities
have taken steps toward these goals with adoption of the European
Standard Set (ESS) [1,2] and proposal of the expanded CODIS core
loci [3,4].
The PowerPlex1 Fusion System allows simultaneous ampliﬁ-
cation of the loci: Amelogenin, D3S1358, D1S1656, D2S441,
D10S1248, D13S317, and Penta E labeled in ﬂuorescein;
D16S539, D18S51, D2S1338, CSF1PO, and Penta D labeled in
JOE; TH01, vWA, D21S11, D7S820, D5S818, TPOX, and DYS391
labeled in TMR-ET; D8S1179, D12S391, D19S433, FGA, and
D22S1045 labeled in CXR-ET. The system incorporates the
expanded CODIS – required loci plus the optional markers, Penta
E, Penta D, D22S1045, and TPOX, and addresses the updated ESS
requirements (Supplemental Table 1). Proﬁles generated using the
PowerPlex1 Fusion System are compatible with databases
founded on either CODIS or ESS requirements. Based on current
5-dye technology, the system is compatible with the Applied
Biosystems1 3130 and 3500 Series Genetic Analyzer capillary
electrophoresis instruments and does not require upgrades to
existing collection and analysis software versions. The PowerPlex1
Fusion System was developed to amplify both extracted DNA and
DNA from solid support materials such as FTA1 cards, swabs, and
nonFTA punches without compromising performance. This ap-
proach allows one system to be used for both casework and
database activities.
Supplementary table related to this article can be found, in the
online version, at doi:10.1016/j.fsigen.2014.04.013.
Developmental validation was performed to demonstrate the
quality and robustness of the PowerPlex1 Fusion System across a
number of variables. SWGDAM, 2004 guidelines [5] were followed,
although the results also meet the 2012 guidelines [6]. Consistent
and high-quality results were compiled using data from 12
separate forensic and research laboratories including the Michigan
State Police casework and CODIS units, US Army Criminal
Investigation Laboratory casework and database units, Arkansas
State Crime Laboratory, Kansas Bureau of Investigation, Texas
Department of Public Safety, Kentucky State Police, New Hamp-
shire State Police, Washington State Patrol Crime Laboratory
Division, Los Angeles County Sheriff’s Department, Oklahoma State
Bureau of Investigation, National Institute of Standards and
Technology (NIST), and Promega Corporation. Studies evaluated
robustness and performance with case-type samples, sensitivity
samples, inhibitors, mixtures, and several PCR conditions. The
conclusions reported here support the fact that the PowerPlex1
Fusion System is suitable for human identiﬁcation in casework and
database applications.
2. Materials and methods
2.1. Samples
Extracted DNA and solid support materials including FTA1 card
punches (GE Healthcare), cotton swabs, and nonFTA Bode BuccalDNA CollectorsTM (Bode Technology Group) were evaluated. Each
laboratory examined its own extracted DNA samples for the
majority of the studies. However, the sensitivity, mixture, and
reproducibility DNA samples were prepared by a single site and
distributed. DNA was puriﬁed by organic extraction for all studies
except case-type samples, which were extracted using EZ11
reagents and instrumentation (Qiagen) in addition to organic
extraction. Unless otherwise noted, 500 pg of extracted DNA was
ampliﬁed.
Laboratories evaluated buccal Indicating FTA1 cards or Bode
Buccal DNA CollectorsTM from their own collections for all studies
outside of the reproducibility studies. For the reproducibility
studies, single donors collected a series of cotton swabs, Indicating
FTA1 cards, or Bode Buccal CollectorsTM for distribution to
multiple sites. Single 1.2 mm punches from buccal Indicating
FTA1 cards were added directly to reactions. Swabs and nonFTA
punches required a pretreatment step prior to addition into
ampliﬁcation reactions. Buccal cotton swab samples were incu-
bated in SwabSolutionTM Reagent (Promega Corporation) as
directed in the technical manual [7], and 2 ml of the resulting
lysate was added as the template to ampliﬁcation reactions. Single
1.2 mm nonFTA punches from Bode Buccal DNA CollectorsTM were
treated with PunchSolutionTM Reagent (Promega Corporation) as
described in the technical manual [8]. Once treated, PCR
ampliﬁcation mix was added to the well and ampliﬁcation
performed.
The species cross-reactivity study was performed using a
number of commercially available non-human DNAs. Ten nano-
grams of each domestic animal or microbial species was ampliﬁed
in duplicate. Species samples included chicken, pig, mouse, bovine,
cat, dog, rabbit, deer, horse, Escherichia coli, Enterococcus faecalis,
Lactobacillus acidophilis, Streptococcus mutans, Staphylococcus
epidermidis, Micrococcus luteus, Fusobacterium nucleatum, Strepto-
coccus salivarius, Streptococcus mitis, Acinetobacter lwofﬁ, Pseudo-
monas aeruginosa, Candida albicans, and Saccharomyces cerevisiae.
Three primate species, chimpanzee (male; Coriell Institute),
macaque (male; Coriell Institute), and gorilla (gender unknown;
privately obtained), were evaluated using 500 pg. The sensitivity
study utilized two DNA dilution series provided to all test sites.
Test quantities included 500 pg, 200 pg, 100 pg, and 50 pg. An
inhibitor study evaluated hematin (Sigma–Aldrich), humic acid
(Sigma–Aldrich), tannic acid (Sigma–Aldrich), and EDTA (Sigma–
Aldrich) titrations. Each inhibitor study site prepared its own
extracted DNA, inhibitor stocks and dilutions. Two mixture series,
one male–male and one male–female, were prepared and
distributed. Mixture ratios included 0:1, 1:19, 1:9, 1:5, 1:2, 1:1,
2:1, 5:1, 9:1, 19:1, and 1:0 for each series. The total template
quantity was 500 pg per reaction. Concordance was performed
with extracted DNA from 652 unrelated individuals from Cauca-
sian, Hispanic, African-American, and Asian-American ethnic
groups. Reaction volume studies used 1.2 mm punches of blood
on Indicating FTA1 cards, in addition to buccal Indicating FTA1
cards described previously.
2.2. DNA ampliﬁcation
Ampliﬁcation reactions were performed at 25 ml volumes on a
GeneAmp1 PCR System 9700 thermal cycler using a 96-well silver
or gold block and max ramp rates as described in the PowerPlex1
Fusion System Technical Manual [9], unless otherwise noted. The
thermal cycling method for extracted DNA samples was: 96 8C for
1 min; 30 cycles of 94 8C for 10 s, 59 8C for 1 min, and 72 8C for 30 s,
followed by a 60 8C ﬁnal extension for 10 min and a 4 8C soak. The
cycle number and ﬁnal extension hold time was modiﬁed for solid
support materials due to the substantial increase in template
amount with these materials. FTA1 card punches were ampliﬁed
Fig. 1. Electropherograms showing detectable peaks with the indicated species
using the PowerPlex1 Fusion System. Peaks were detected with 10 ng of chicken,
mouse, or pig DNA. Samples were detected using an Applied Biosystems1 3130xl
Genetic Analyzer with a 3 kV 5 s injection. Peak amplitude threshold was 50 RFU
(n = 2).
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treated nonFTA punches were ampliﬁed for 25 or 26 cycles. All
ampliﬁcation reactions with solid support substrates utilized a
20 min ﬁnal extension. Further cycle number optimization was
evaluated in a cycle number study. Within that study extracted
DNA samples were ampliﬁed for 29, 30, and 31 cycles, FTA1 card
punches for 26, 27, and 28 cycles, and treated nonFTA punches for
25, 26, and 27 cycles. A reduced reaction volume study compared
Bode Buccal DNA CollectorTM punch ampliﬁcation reactions in the
presence or absence of AmpSolutionTM Reagent (Promega Corpo-
ration). Reactions with AmpSolutionTM Reagent were assembled as
described in the Ampliﬁcation Setup for AmpSolutionTM –
Dependent PowerPlex1 Systems section in the PunchSolutionTM
Kit Technical Manual [8]. Brieﬂy, 5 ml of water was replaced with
5 ml of AmpSolutionTM Reagent per reaction.
2.3. Ampliﬁcation analysis
For sample detection 1 ml of ampliﬁcation product or allelic
ladder was combined with 1 ml of CC5 Internal Lane Standard
(Promega Corporation) and 10 ml of HiDiTM Formamide (Life
TechnologiesTM). Samples were denatured at 95 8C and snap-
cooled on ice for 3 min. Sample detection was performed using the
Applied Biosystems1 3130 and 3500 Series Genetic Analyzers and
an Applied Biosystems1 3730 DNA Analyzer (Life Technolo-
giesTM). Spectral resolution for all three instruments was
established on the G5 dye set using the PowerPlex1 5-Dye Matrix
Standards, 3100/3130 (Promega Corporation). The 3130 and 3500
Series Genetic Analyzers were run using POP-41 polymer (Life
TechnologiesTM). However, the 3730 DNA Analyzer was run using
POP-7TM polymer (Life TechnologiesTM). All capillary electropho-
resis instruments used a 36-cm array. Injections on the 3130
Series Genetic Analyzer were performed at 3 kV for 5 s, except a
1.5 kV 5 s injection was used in the reaction volume and cycle
number studies to reduce signal saturation. Additionally, an initial
concordance study was performed using 1 kV 3 s injections and a
conﬁrmatory concordance study used 2 kV 5 s injections. Injec-
tions on the 3500 Series Genetic Analyzer were performed at
1.2 kV for 10 s or 24 s. The stutter study, however, was conducted
using a 1.2 kV 18 s or 1.2 kV 12 s injection. The 3730 DNA Analyzer
used a 3 kV 5 s injection.
Data analysis was performed using GeneMapper1 ID Software
version 3.2 or GeneMapper1 ID-X Software version 1.2 (Life
TechnologiesTM) with the PowerPlex1 Fusion panel, bin, and
stutter ﬁles version 1.0. The minimum analytical threshold varied
with instrumentation and test site. Validation sites used previously
validated minimum thresholds which were based on internal peak
height preferences and instrument performance. Thresholds from
each validation site were preserved, especially with sensitivity and
mixture tests, to normalize the peak height preferences between
sites. By using analysis methods speciﬁc to individual data sets, the
collective results are more consistent between sites and more
reﬂective of typical laboratory performance. In general, data
collected on the 3500 Series Genetic Analyzer utilized a 175 RFU
threshold, and the 3730 DNA Analyzer used a 100 RFU threshold.
The minimum threshold with the 3130 Series Genetic Analyzer
varied from 50 to 175 RFU. Any departures from these thresholds
are listed below.
The species study used a 50 RFU threshold with 3130xl Genetic
Analyzer data. The sensitivity study employed a 50, 75, or 100 RFU
threshold with the 3130 Series Genetic Analyzer data, a 50 RFU
threshold with the 3500 Genetic Analyzer data, and a 100 RFU
threshold with the 3730 DNA Analyzer data. The inhibitor study
data from 3130 Series Genetic Analyzers was analyzed with a
50 RFU or 150 RFU threshold. The reaction volume study used a
50 RFU threshold with 3130 Series Genetic Analyzer data.Reproducibility testing employed 50, 150, or 175 RFU thresholds
with 3130 Series Genetic Analyzer data. Analysis of case-type
samples used a threshold of 75 RFU with the 3130 Series Genetic
Analyzer data and 175 RFU with the 3500 Series Genetic Analyzer
data. Mixture analysis utilized 50, 75, or 100 RFU thresholds with
the 3130 Series Genetic Analyzers data. The concordance studies
used a 50 RFU threshold with the 3130 Series Genetic Analyzer
data.
3. Results
3.1. Species cross-reactivity
Cross-reactivity with environmental microbial species or other
non-human species should be minimal to ensure human data is
not obscured. Multiple macro- and microorganism species DNAs
were ampliﬁed with the PowerPlex1 Fusion System to demon-
strate low cross-reactivity with non-human species. Ten nano-
grams of each domestic animal or microbial species was ampliﬁed
in duplicate for 30 cycles. Species samples included chicken, pig,
mouse, bovine, cat, dog, rabbit, deer, horse, E. coli, E. faecalis, L.
acidophilis, S. mutans, S epidermidis, M. luteus, F. nucleatum, S.
salivarius, S. mitis, A. lwofﬁ, P. aeruginosa, C. albicans, and S.
cerevisiae. Three non-human primate species, chimpanzee (male),
macaque (male), and gorilla (gender unknown), were evaluated
using 500 pg.
No ampliﬁcation products were detected with most domestic
species or any of the microbial species tested. Minimal peaks were
observed with 10 ng of chicken, pig, and mouse DNA, and those
peaks were located between panels or called off-ladder. Chicken
DNA generated a peak in the JOE channel at approximately 216
bases between the D18S51 and D2S338 panels. Pig DNA produced a
peak in the JOE channel at approximately 365 bases between the
CSF1PO and Penta D panels. Lastly, mouse DNA generated an off-
ladder peak at approximately 180 bases in the ﬂuorescein channel
at D1S1656 (Fig. 1). As expected due to the genetic similarities
between humans and other primates, the three non-human
primate samples generated multiple on and off-ladder peaks,
although they were clearly distinct from human proﬁles (data not
shown).
Fig. 2. Percent alleles called (left-hand axis; light gray) and average sample peak
height ratio (right-hand axis; dark gray) over a DNA titration from 500 pg to 50 pg.
Samples were detected using an Applied Biosystems1 3130 and 3500 Series Genetic
Analyzers using 3 kV 5 s or 1.2 kV 10 s injections, respectively, and a 3730 DNA
Analyzer using a 3 kV 5 s injection. Error bars represent standard deviation (n = 36).
Fig. 3. Electropherograms showing D12S391 allele 18.3 with the allele 19 shoulder.
Samples were detected using the Applied Biosystems1 3500xl and the 3130xl
Genetic Analyzers with a 1.2 kV 24 s or 3 kV 5 s injection, respectively. Similar
resolution was observed on the Applied Biosystems1 3730 DNA Analyzer.
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To evaluate performance across a range of DNA quantities, ﬁve
sites tested two extracted DNA dilution series. Final quantities of
500 pg, 200 pg, 100 pg, and 50 pg were ampliﬁed in triplicate for 30
cycles. Further data analysis was performed to assess the inter-
allelic peak height ratios by dividing the minimum heterozygous
allele peak height by the maximum heterozygous allele peak
height. Sample detection was performed on 3130 and 3500 Series
Genetic Analyzers and a 3730 DNA Analyzer. Individual laboratory
analysis thresholds were preserved to normalize peak height
preferences and instrument noise at each site.
DNA quantities of 100 pg and greater allowed assignment of
100% of the expected alleles (Fig. 2). At 50 pg, the percent alleles
called dropped slightly to 97.2%. Drop out did not occur regularly at
a particular locus, but sporadically amongst loci. Similar sensitivity
was observed on the 3130 and 3500 Series Genetic Analyzers and a
3730 DNA Analyzer.
Average peak height ratios were greater than 70% at all DNA
quantities over 50 pg, and equal to 70% using 50 pg (Fig. 2). A
decrease in locus peak height ratio was seen with decreasing DNA
quantity, as seen with other STR systems (data not shown). The
3130 and 3500 Series Genetic Analyzers and the 3730 DNA
Analyzer gave equivalent ratios.
3.3. Stability and inhibitor studies
Environmental inhibitors can compound the issue of obtaining
proﬁles from low-level samples by affecting ampliﬁcation perfor-
mance. Typical environmental and puriﬁcation-related PCR-
inhibitors, hematin, humic acid, tannic acid, and EDTA, were
titrated into PowerPlex1 Fusion reactions containing extracted
DNA or FTA1 card punches. Two validation sites evaluated
performance using 3130 Series Genetic Analyzers with a 3 kV
5 s injection.
Full, concordant proﬁles were obtained with hematin concen-
trations 1000 mM using extracted DNA at Site 1 and 500 mM
using extracted DNA or an FTA1 card punch at Site 2 (Supplemen-
tary Fig. 1). With humic acid, full proﬁles were generated with
200 ng/ml using extracted DNA and 100 ng/ml using FTA1 card
punches (Supplementary Fig. 2). Full proﬁles were generated with
100 ng/ml to 300 ng/ml tannic acid using extracted DNA depending
on test site and 300 ng/ml using an FTA1 card punch
(Supplementary Fig. 3). Lastly, full proﬁles were obtained with
0.4 mM EDTA using either extracted DNA or an FTA1 card punch
(Supplementary Fig. 4). Slight differences in inhibitory concentra-
tions were observed between sites. The results are likely due to
variation in the creation and dilution of the inhibitory compounds
separately at each validation site. Because the compoundsnecessary for room-temperature storage can cause PCR inhibition,
reactions with FTA1 card punches often generated partial proﬁles
at lower inhibitor concentrations than reactions with extracted
DNA. However, in the EDTA titration study reactions with FTA1
card punches generated signiﬁcantly more allele calls than
reactions with extracted DNA. Reactions with FTA1 card punches
commonly had higher peak heights than reactions with extracted
DNA, allowing more alleles to be called.
Supplementary ﬁgures related to this article can be found, in the
online version, at doi:10.1016/j.fsigen.2014.04.013.
3.4. Reproducibility
A shared genotype database relies on consistent results
between laboratories to generate matches. Several materials were
evaluated to demonstrate genotyping reproducibility and reliabil-
ity. Five sites evaluated panels of extracted DNA, buccal Indicating
FTA1 cards, buccal cotton swabs, and nonFTA Bode Buccal DNA
CollectorsTM with three replicates for each sample. Samples were
detected using 3130 and 3500 Series Genetic Analyzers or a 3730
DNA Analyzer.
Five sites evaluated the NIST SRM2391c PCR-Based DNA
Proﬁling Standard samples A–D. Complete and concordant proﬁles
were gathered at each of the ﬁve test sites for all samples (n = 72),
except with sample D. Sample D was a mixture sample with four
alleles at D12S391: 18.3, 19, 22, and 23. All alleles were
consistently called except the 19 allele. Although the 19 allele
resolved as a distinct shoulder on the 18.3 allele peak, neither the
GeneMapper1 ID nor the GeneMapper1 ID-X software called the
minor contributor 19 allele (Fig. 3). Similar resolution was seen
across all replicates on the 3130 and 3500 Series Genetic Analyzers
and a 3730 DNA Analyzer, and can be expected with closely spaced
minor contributor alleles.
Complete and concordant proﬁles were gathered from multiple
solid support substrates. All ﬁve buccal cotton swab samples gave
full and concordant proﬁles from both test sites (n = 45). A
complete and concordant proﬁle was seen for four buccal
Indicating FTA1 card samples and SRM2391c sample F (cells
spotted onto an FTA1 card) at each of four test sites (n = 70). Five
Table 1
Case-type samples evaluated with the PowerPlex1 Fusion System. Four validation sites evaluated performance with 76 samples from their own collections. Complete,
expected proﬁles were collected with at least one sample within each category, except blood with soil, leather, and mixture samples, which generated partial, expected
proﬁles.
Sample type Extraction Full
proﬁle
n
Blood from liquid sample, FTA1 card, or WhatmanTM paper EZ11, Organic 21 23
Cigarette butts EZ11 2 3
Buccal swab EZ11 7 10
Differential extractions (epithelial and sperm fractions from 2 samples) EZ11 4 4
Touch samples EZ11 4 12
Blood with soil EZ11 0 1
Case-type mixtures (<300 pg input, multiple donors) EZ11 0 4
Leather with blood stain EZ11 0 1
Hair root Organic 9 9
Saliva Organic 7 9
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SRM2391c sample E (cells spotted onto S&S 903 paper) gave full
and concordant proﬁles (n = 54). Two of the sample sources, one
FTA1 card and one Bode Buccal DNA CollectorTM, produced low
peak heights at each evaluation site, presumably due to poor cell
transfer onto the surface or low shedding of buccal cells from the
donor. Any partial proﬁle samples were fully concordant at all
ampliﬁed loci.
Artifacts speciﬁc to the migration of PowerPlex1 Fusion System
ampliﬁcation products on POP-7TM polymer were observed.
Artifacts were labeled by the GeneMapper1 ID Software, version
3.2, at approximately 88 bases in the ﬂuorescein channel and
approximately 90 bases in the JOE channel. All samples except
allelic ladder contained the artifacts, including negative controls.
Artifacts may be reduced by performing sample electrophoresis
immediately after ampliﬁcation. These artifacts were not observed
on POP-41 polymer and are noted in the technical manual [9].
3.5. Case-type samples
Forensic casework samples represent a wide variety of sample
quantity, background contaminants, and biological sample types.
Four validation sites evaluated a total of 76 case-type samples from
their own collections (Table 1). Samples were extracted from a
variety of sources by organic and EZ11 extraction methods.
Detection was performed on either an Applied Biosystems1 3130
or 3500 Series Genetic Analyzer, and data was analyzed with
GeneMapper1 ID-X software.
Full and concordant proﬁles were collected at each site from
multiple sample types including blood, cigarette butts, buccal
swabs, differential extracts, touch samples, mixtures, hair, and
saliva. Little to no allelic drop out was observed when 500 pg of
DNA was ampliﬁed, and several samples with less than 200 pg
yielded full proﬁles. When partial proﬁles were generated,
signiﬁcant genotype information was generally collected.
Although clear ampliﬁcation inhibition was observed in a
reaction with 76 pg of DNA extracted from leather, information
from 14 loci was retrieved (Supplemental Fig. 5). Ampliﬁcation
was seen with all touch samples, and as expected, several
contributors were detected. Samples known to have multiple
contributors produced allele calls consistent with the contribu-
tor proﬁles. Although no single contributor proﬁle was
complete, three of four mixed samples produced signiﬁcant
proﬁle information with at least one allele at all autosomal loci
using 210 pg total template DNA (Supplemental Fig. 6). In
these partial proﬁle case-type samples, allelic drop out occurred
with the largest loci, TPOX, D22S1045, DYS391, and Penta E,
which are either less informative or not required by databases.
Full or signiﬁcant partial proﬁle information was successfullycollected with typical case-type samples using a range of
template amounts.
Supplementary ﬁgures related to this article can be found, in the
online version, at doi:10.1016/j.fsigen.2014.04.013.
3.6. Mixtures
To evaluate mixture detection performance, two mixture series
were created and distributed, one male-male and one female-male,
at the ratios: 1:0, 19:1, 9:1, 5:1, 2:1, 1:1, 1:2, 1:5, 1:9, 1:19, 0:1. Five
sites ampliﬁed a total quantity of 500 pg of DNA for 30 cycles.
Alleles unique to the minor contributor were counted and
presented as a percentage of the total number of unique alleles
expected (percent unique alleles called).
Multiple contributors were detected with all mixture ratios at
all ﬁve test sites. An average of 88% of unique minor contributor
alleles were detected in 1:9 mixture ratios and an average of 55%
were detected in 1:19 mixture ratios (Supplemental Fig. 7). The
minor donor contribution in these samples was 50 pg and 25 pg,
respectively. Similar results were gathered with Applied Biosys-
tems1 3130 and 3500 Series Genetic Analyzers. As the mixture
ratio increased, the average number of alleles detected decreased.
These results are comparable to what has been reported with
smaller, 16- and 17-locus multiplexes [10,11], indicating that the
addition of loci has not compromised performance for mixture
analysis.
Supplementary ﬁgure related to this article can be found, in the
online version, at doi:10.1016/j.fsigen.2014.04.013.
3.7. Concordance
The primer sequences contained within the PowerPlex1 Fusion
System are highly conserved from previously released systems
such as the PowerPlex1 ESI, 18D, and 21 Systems. These primer
sequences have demonstrated a high level of concordance during
product use and concordance testing in previous validation
studies on the original CODIS 13 loci plus D2S1338, D19S433,
Penta E and Penta D [12,13], and the new ENSFI loci [10,11,14]. To
further demonstrate concordance as a complete system, the
National Institute for Standards and Technology (NIST) performed
an initial concordance study comparing genotypes from 652
unrelated individuals using a pre-release PowerPlex1 Fusion
System to commercially available PowerPlex1 16 HS and
PowerPlex1 21 Systems and further compared to AmpFLSTR1
NGMTM, IdentiﬁlerTM, YFilerTM, Proﬁler1, MiniﬁlerTM and
SinoﬁlerTM PCR Ampliﬁcation Kits (Life TechnologiesTM), and
Investigator1 ESSplex Plus and IDplex Plus systems (Qiagen). At
its commercial release a minor change was made to the D16S539
primers. A conﬁrmatory concordance study was performed using
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using an Applied Biosystems1 3130 Series Genetic Analyzer with
a 1 kV 3 s injection for the original sample set and 2kv 5 s injection
for the conﬁrmatory sample set.
Three discordant calls out of 39,198 alleles tested were
observed at amelogenin, D7S820, and D22S1045. No discordances
were observed at D16S539 with the updated primers. One
discordant sample generated Y, Y results at amelogenin with the
PowerPlex1 Fusion System and all other systems except Investi-
gator1 ESSplex Plus and IDplex Plus. In the second sample,
sequencing conﬁrmed 8 and 11 alleles at D7S820. The 8, 11
genotype was generated using the PowerPlex1 16 and MiniﬁlerTM
systems. However, the PowerPlex1 Fusion, Proﬁler1, SinoﬁlerTM,
and PowerPlex1 21 systems produced an 8, 9.3 genotype. A
deletion is suspected between the primer binding sites of the two
sets of systems. Finally, a previously unknown discordance was
observed at D22S1045. Well balanced 14, 17 alleles were ampliﬁed
using the PowerPlex1 ESI and ESX Systems. In contrast,
ampliﬁcation using the PowerPlex1 Fusion System yielded a
severely imbalanced 14 allele. The PowerPlex1 Fusion System is
suitable for comparison with previously gathered proﬁles from
multiple systems, as the observed discordances were rare and
unique.
3.8. Precision
Allele calls rely on similar migration between the sample and
allelic ladder standard. Therefore, migration and sizing precision
must be consistent and within the bin window for accurate allele
calls. To demonstrate precision, allelic ladders were detected at
ﬁve sites on Applied Biosystems1 3130 and 3500 Series Genetic
Analyzers and an Applied Biosystems1 3730 DNA Analyzer. This
study addressed typical sources of variability such as differences
between capillaries and injections. Standard deviations in sizing
were calculated for each allele.
The maximum standard deviation of an allele was 0.1 bases
on the 3130xl and 3500xl Genetic Analyzers (Fig. 4 and
Supplemental Fig. 8). Comparable results were gathered
between the four sites with all genetic analyzers tested. The
3130 Genetic Analyzer and 3730 DNA Analyzer generated more
variability than the other instruments (Supplemental Fig. 9). The
maximum standard deviation of any allele was 0.16 bases,
observed at FGA with the largest alleles (44.2–50.2), on both
instruments. The 0.5-base bin window set by the bin ﬁle is
greater than three standards deviations of either 0.1 or 0.16
bases, the largest sizing variations observed. Sizing variability
increased with locus and allele size. Those loci with the largest
sizes; FGA, Penta D, DYS391, TPOX, and Penta E, had alleles with
the greatest standard deviations.Fig. 4. Size standard deviation for each allele within the PowerPlex1 Fusion Allelic
Ladder Mix. One microliter of allelic ladder was detected using a Applied
Biosystems1 3500xl Genetic Analyzer at Promega Corporation using a 1.2 kV
24 s injection. Similar results were obtained at two other sites (n = 48).Supplementary ﬁgures related to this article can be found, in the
online version, at doi:10.1016/j.fsigen.2014.04.013.
3.9. Stutter
Ampliﬁcation of repeat sequences by DNA polymerases often
produces slippage products one or more repeat units shorter or
larger than the true sequence length [15,16]. Because the level of
stutter products as a percentage of the full-length allele products
remains roughly constant, ﬁlters can be constructed to remove
allele calls on stutter position peaks below that stutter percentage.
To calculate the average observed stutter for each locus, 116
unrelated genomic DNAs were ampliﬁed with the PowerPlex1
Fusion System for 30 cycles. Samples were detected using an
Applied Biosystems1 3500xl Genetic Analyzer using a 1.2 kV 18 s
or 1.2 kV 12 s injection. A peak height ratio of the stutter peak
height to the allele peak height was calculated. To ensure accurate
calculation of the true stutter ratio, allele peak heights greater than
30,000 RFU and less than 175 RFU were removed from the data set.
Stutter peaks that resided between two true alleles two repeats
apart (e.g., 8, 10) were removed as well. Peaks in this position are
often inﬂated due to the additive effect of minus and plus stutter
peaks migrating at the same size.
The stutter ﬁlter for the GeneMapper1 ID and ID-X ﬁles is set as
the mean stutter ratio at each locus plus three standard deviations.
The GeneMapper1 ID-X stutter ﬁle includes ﬁlters for plus stutter
for the trinucleotide repeat locus D22S1045 and the n  2 peak
seen with D1S1656. The highest stutter percentages were seen
with D12S391 and D1S1656, and the stutter ratio increased with
increasing repeat number. The stutter data and summary are
presented in Supplemental Tables 2 and 3.
Supplementary tables related to this article can be found, in the
online version, at doi:10.1016/j.fsigen.2014.04.013.
3.10. Reaction volume
Laboratories commonly reduce reaction volume for cost-saving
purposes. Although recent STR system improvements have allowed
the use of a variety of solid support substrates containing inhibitory
chemicals, ampliﬁcation reactions using these materials with
reduced reaction volumes can be negatively affected. Results with
reduced reaction volumes of 12.5 ml and 6.25 ml were compared
with results with standard 25 ml reaction volumes using extracted
DNA, 2 ml cotton swab lysate, FTA1 card punches, and nonFTA
punches. A further study compared results with one and two
punches of buccal and blood FTA1 card in 25 ml, 12.5 ml, and 6.25 ml
reaction volumes. Samples were detected using Applied Biosys-
tems1 3130 Series Genetic Analyzers with a 3 kV 5 s injection.
Full proﬁles were generated for all extracted DNA and swab
lysates at 25 ml, 12.5 ml, and 6.25 ml reaction volumes (Fig. 5).
Little variability was observed. Extracted DNA and swab lysates areFig. 5. Percent alleles called using extracted DNA or pretreated solid support
materials with reduced-volume reactions. Samples were detected using Applied
Biosystems1 3130xl Genetic Analyzers with a 3 kV 5 s injection. Error bars
represent standard deviation. (Extracted DNA, n = 3; Swab lysate, n = 4; FTA1 card
punch, n = 27.)
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variability.
Successful ampliﬁcation was achieved using one buccal FTA1
card punch in 25 ml and 12.5 ml reaction volumes (Fig. 5). Over
90% of the alleles were called at volumes 12.5 ml and greater.
Reaction volumes of 6.25 ml showed a signiﬁcant decrease in allele
calls and a sharp rise in reaction failures. Sampling variability was
observed with this substrate.
In a more comprehensive examination of FTA1 card samples,
successful ampliﬁcation was observed in 12.5 ml reactions using
one blood FTA1 card punch. Two punches from either buccal or
blood FTA1 cards in 12.5 ml reactions regularly allowed successful
ampliﬁcation; however, allele drop out and ampliﬁcation failures
increased compared to reactions using one punch (Supplemental
Fig. 10). With 6.25 ml reaction volumes less than 50% of the
expected alleles were called with one or two punches of buccal or
blood FTA1 cards. Ampliﬁcation was unreliable and several
complete failures were seen.
Supplementary ﬁgure related to this article can be found, in the
online version, at doi:10.1016/j.fsigen.2014.04.013.
In initial testing PunchSolutionTM-treated nonFTA punches
demonstrated a clear reduction in percent alleles called in 12.5 ml
reactions, and no ampliﬁcation was observed with 6.25 ml reaction
volumes. The lytic chemicals in the PunchSolutionTM Reagent
presumably overwhelmed the reactions with signiﬁcantly reduced
reaction volumes. Further testing was performed with AmpSolu-
tionTM Reagent to improve ampliﬁcation of nonFTA punches in
reduced volume reactions. PunchSolutionTM-treated nonFTA
punches were ampliﬁed in the presence and absence of
AmpSolutionTM Reagent at a reaction volume of 25 ml, 12.5 ml,
or 6.25 ml. The percentage of alleles called was signiﬁcantly
increased at 12.5 ml and 6.25 ml reaction volumes in the presence
of AmpSolutionTM Reagent compared to reactions ampliﬁed
without AmpSolutionTM Reagent (Fig. 6).
3.11. Cycle number
The amount of ampliﬁable DNA on solid support materials can
vary widely, and therefore results can beneﬁt from cycle number
optimization. Three sites examined extracted DNA, FTA1 card
punches, or nonFTA punches from their own collections with
varying cycle numbers. Extracted DNA was evaluated using 29, 30,
and 31 cycles; FTA1 card punches using 26, 27, and 28 cycles; and
nonFTA punches using 25, 26, and 27 cycles. Samples were
detected using Applied Biosystems1 3130 and 3500 Series
Genetic Analyzers using 3 kV 5 s and 1.2 kV 24 s injections,
respectively. A 1.5 kV 5 s injection on an Applied Biosystems1
3130 Series Genetic Analyzer was used with one donor to reduce
signal saturation.
Full proﬁles were detected for extracted DNA and nonFTA
punches at all cycle numbers tested. FTA1 card punches generatedFig. 6. Percent alleles called using nonFTA punches as the template source in
reduced-volume reactions. Reactions were ampliﬁed in the presence and absence of
AmpSolutionTM Reagent (n = 6).full proﬁles at both 27 and 28 cycles. At the lowest cycle number
tested, 26 cycles, 98% of alleles were called; 11 of the 12 FTA1 card
punches yielded full proﬁles, while one yielded only a partial
proﬁle. This sample gave exceptionally low signals compared to
the other two replicates from the same donor’s FTA1 card. With
all substrates, peak heights rose steadily with each additional
cycle, as expected, and signals were often saturated at the
highest cycle number tested. Signal strength with increasing
cycle number using solid support materials was highly variable
but collectively resulted in signal increases similar to extracted
DNA. Robust ampliﬁcation was observed using cycle numbers
lower than suggested at multiple sites, demonstrating the
recommended cycle numbers can accommodate a range of
material sources.
When following the recommended template quantity and cycle
numbers, artifacts in D18S51 at 214 bases, TH01 at 76 bases, and
D12S391 at 176–180 bases commonly remain under the minimum
threshold. Increased sample signal, particularly at high cycle
number, directly correlated with an increase in the incidence of
called artifacts and artifact peak height.
3.12. Annealing temperature
Departures from the optimal annealing temperature can reduce
yields or generate artifacts which can affect data interpretation.
Annealing temperatures 2 8C above and below the recommended
annealing temperature of 59 8C were evaluated by amplifying
extracted DNA and FTA1 card punches. Samples were detected
using an Applied Biosystems1 3130 Series Genetic Analyzer with a
3 kV 5 s injection.
Full proﬁles were observed for extracted DNA and FTA1 card
punches at all temperatures tested: 57 8C, 59 8C, and 61 8C. A slight
increase in artifacts was observed at 57 8C, two degrees below the
recommended annealing temperature. An off-ladder artifact in
D18S51 at 214 bases and an artifact in D12S391 at 180 bases were
observed only in extracted DNA samples (Supplemental Fig. 11).
These artifacts were below the 50 RFU minimum analytical
threshold at 59 8C but, at 57 8C, increased slightly to rise above the
threshold.
Supplementary ﬁgure related to this article can be found, in the
online version, at doi:10.1016/j.fsigen.2014.04.013.
3.13. Magnesium titration
Extensive master mix optimization was performed during
development to achieve robust ampliﬁcation without the intro-
duction of nonspeciﬁc artifacts. However, a number of inhibitors
and common template storage buffers can affect the available
magnesium within a reaction. To determine the effect of
magnesium concentration on sample results, extracted DNA,
cotton swab lysate, FTA1 card punches, and nonFTA punches
were tested at magnesium concentrations 20% above and below
the commercial formulation. Detection was performed using an
Applied Biosystems1 3130 Series Genetic Analyzer with a 3 kV 5 s
injection.
Full proﬁles were generated at 20% magnesium concentrations
for extracted DNA and swab lysates. Full proﬁles were observed with
FTA1 card punches using 1X and +20% magnesium concentrations
and with PunchSolutionTM-treated nonFTA samples using 1X and
20% magnesium concentrations (Supplemental Table 4). In reac-
tions with FTA1 card punches and decreased magnesium, 99% of
alleles were called. The D22S1045 alleles dropped out in one of the six
FTA1 card punch replicates. In the nonFTA punch reactions with a
+20% magnesium concentration, 99% of alleles were called, with one
of the six replicates yielding low peak heights compared to the other
replicates which caused the DYS391 allele to drop out.
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Minimal artifacts were observed with increased magnesium
concentration. Reactions with swab lysates and nonFTA punches
showed no additional artifacts with increased magnesium.
Extracted DNA and one of two FTA1 card donors produced a
low-level artifact in D12S381 at 180 bases in the +20% samples that
was not present in the 1X magnesium reactions. FTA1 card
punches from two donors generated a low-level off-ladder artifact
in D18S51 at 185 bases that was observed with increased
magnesium (data not shown).
3.14. Primer titration
To determine the effect of primer concentration changes on the
PowerPlex1 Fusion System results, extracted DNA and FTA1 card
punches were evaluated with primer concentrations 25% above
and below the recommended concentration. Samples were
detected using an Applied Biosystems1 3130 Series Genetic
Analyzer with a 3 kV 5 s injection.
Full proﬁles were generated with both extracted DNA and FTA1
card punches at all primer concentrations tested. Little impact was
seen on peak heights with variation in primer concentration, and
no discrete artifact peaks developed. However, a 25% increase in
primer concentration created more minus A product in reactions
with extracted DNA than reactions with the recommended primer
concentration. This effect was not as pronounced using FTA1 card
punches.
4. Conclusions
The PowerPlex1 Fusion System was developed for human
identiﬁcation STR analysis of casework and reference samples
using extracted DNA and solid support substrates. Following
SWGDAM and NDIS validation guidelines, 12 forensic and
research laboratories demonstrated strong performance through-
out validation testing for the PowerPlex1 Fusion System. Minimal
cross-reactivity, low-level sensitivity and mixture detection,
precise and accurate allele calls, and robust performance with
casework samples and in the presence of inhibitors were
observed. Strong ampliﬁcation and minimal artifacts were
generated under several suboptimal PCR conditions. Multiple
DNA sources encompassing extracted DNA, FTA1 card punches,
swabs, and nonFTA punches produced full and concordant
proﬁles. These validation results verify that the PowerPlex1Fusion System is a robust and reliable STR-typing multiplex
suitable for human identiﬁcation.
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